APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 10, n. 1, p. e2018028, 2018. DOI: 10.4084/mjhid.2018.028. Disponível em: https://www.mjhid.org/mjhid/article/view/2018.028. Acesso em: 27 may. 2026.